With over 350 branches in the UK, Medivet is a leading provider of veterinary care, delivering a full spectrum of small animal health services including routine check-ups, 24/7 emergency care, lab & diagnostics and advanced surgery to companion pets across the country. Medivet has a clinical excellence led ethos and unique partnership model delivering a gold-standard of clinical care to patients, whenever and wherever they need it. From its UK foundations, the company has recently expanded with operations in Germany and Spain, with ~50 sites in Europe in partnership with local founders.
With CVC Funds' backing, Medivet will pursue a strategy focused on driving both organic and inorganic growth, while further enhancing Medivet's established reputation for exceptional care and service to its clients. Benefitting from both CVC's UK presence and strong international reach, Medivet is poised to continue its growth as a leading provider of veterinary services in the attractive animal health and wellness sector.
Commenting on the announcement, Deirdre Burns, CEO of Medivet said: "I am delighted that CVC has decided for its fund' to invest in Medivet to fuel and support our ambitions and growth plans for the UK and Europe, and look forward to working together to bring them to fruition. Over the last 34 years, our Central Partners, Branch Partners and all our people have worked hard to build an outstanding business, centred on delivering exceptional care and service to our patients and clients. In the last few years, the management team have built upon these foundations, transforming the professionalism of our functions and operation, and we are primed to continue our expansion – both in market presence and in the depth of our clinical care, service and expertise."
Arnold Levy, on behalf of the founders of Medivet, said: "It is with great pride that we see Medivet in the position it is today, and would like to extend our congratulations to all our outstanding staff who endeavour daily to make pets' lives better. Deirdre and her management team have worked tirelessly to build on the Company's track record in recent years, and to ensure it is well placed to continue its growth in the years to come. In CVC, we have found a new investor and partner who appreciate our industry, our business and its model and we wish them all the best for the next phase of the journey."
Dominic Murphy, Managing Partner and Co-Head of UK Investments at CVC, commented: "Medivet is a fast growing and attractive business, where we are delighted to be backing the management team, led by CEO Deirdre Burns, to further grow the UK business and accelerate international expansion. CVC Funds have significant experience investing in similar service-based healthcare businesses across Europe, and believe we can use these learnings to support the team effectively."
Phil Robinson, Managing Director in CVC's Healthcare team added: "Having practiced as a veterinary surgeon myself, I can appreciate the outstanding capabilities of the vets, nurses and practice staff within Medivet. We at CVC now look forward to supporting the Company to provide them with the necessary tools and resources to continue delivering excellent clinical care to their patients."
The transaction is expected to close in Q4 2021 subject to regulatory approvals. CVC were advised by Jefferies, Freshfields, PWC, LEK, Mansfield Advisors and Goldman Sachs. Medivet was advised by HSBC, Travers Smith, KPMG and EY.